CIDRAP newsletters options
Among children, COVID-19 was the eighth-leading cause of death from any cause and first in deaths caused by infectious or respiratory disease.
Deaths and struggling health systems are among ongoing concerns, and the group will likely meet again in 3 months to reassess developments.
A randomized trial in Canada finds that COVID-19 patients in the audit and feedback group had lower antibiotic use but similar outcomes to patients treated with standard of care.
The NSABB endorses findings from two of its working groups, one on oversight of potential pandemic pathogens and the other on dual-use research of concern.
Boosters lower the risk of death among adults more than 90% and increase protection against severe disease in children aged 5 to 11 years by 77%, new data reveal.
A 5-year study of US hospital data illustrates trends in E coli and Klebsiella pneumoniae isolates carrying beta-lactamase antibiotic resistance genes.
The bivalent booster offered additional benefits against symptomatic infection and severe illness, 3 new studies show.
In another COVID development, the FDA pulled its EUA for Evusheld, the last available monoclonal antibody treatment, due to weak activity against the newer circulating subvariants.
While poor-quality and contaminated drugs endanger consumers in many countries, including the US, they can be catastrophic in those not equipped to conduct inspections.
Data show the share of Americans reporting long COVID has dropped over the past 6 months, while another study suggests vaccination may contribute to lower levels of long COVID.
Residents not up to date on recommended COVID-19 vaccines were at a 30% to 50% higher risk for infection.
The deer was a 2-year-old doe harvested by a hunter in the northwestern part of the county.
Commercial turkey farms in Iowa and Virginia were hit, affecting almost 40,000 birds.
The WHO and its partner organizations say the group will help guide countries in their efforts to monitor antimicrobial use and resistance.
FDA advisers recommend offering just the newer bivalent versions of the vaccine for both primary and booster series.
Global cases have declined 25% in the previous 4 weeks, but deaths rose 13%.
The positivity rate of home tests was comparable to official results through June 2022 but then started to drop off.
The study shows people with dementia faced continued challenges in care even after the acute phase of the pandemic.
The state will launch a pilot program to test wastewater for flu, hepatitis A, norovirus, and antimicrobial-resistance genes.
The tool tests human and animal healthcare professionals on their knowledge and awareness of antibiotic resistance.
